{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-063707","form_type":"8-K","ticker":"TCNNF","cik":"0001754195","company_name":"Trulieve Cannabis Corp.","filed_at":"2023-03-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:46.418694+00:00","generated_at":"2026-06-18T08:38:11.579817+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Trulieve reports record FY2022 revenue of $1.24B, Q4 net loss of $77M","bullets":["FY2022 revenue $1.24B (+32% YoY); Q4 revenue $302M, 2% sequential retail growth.","Q4 GAAP gross margin 50%; net loss $77M; adjusted net loss $35M; adjusted EBITDA $85M (28% revenue).","Q4 operating cash flow $55M, free cash flow $21M; inventory reduced $4M vs Q3 build of $32M.","Closed $90M in commercial loans at avg 7.5% interest; opened 5 new dispensaries; total 181 dispensaries."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-063707","json":"https://secwatch.observer/filing/0001193125-23-063707.json","markdown":"https://secwatch.observer/filing/0001193125-23-063707.md","text":"https://secwatch.observer/filing/0001193125-23-063707.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1754195/000119312523063707/0001193125-23-063707-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1754195/000119312523063707/d480555d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T08:38:11.579817+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"bad9288817d020a0e52e1b1704d9fb04ea1310fc","claim":"Trulieve Cannabis Corp. reported fourth quarter and year ended December 31, 2022 results: revenue $302 million, net income net loss of $77 million.","evidence_excerpt":"Fourth Quarter and Record Full Year 2022 Results Exceeding $1.2 Billion in Revenue • Record revenue of $1.24 billion in 2022, up 32% year over year, and quarterly revenue of $302 million, with 2% retail revenue growth sequentially • Industry leading U.S. retail network of 181 dispensaries, up 14% from 2021, supported by over 4 million square feet of cultivation","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1754195/000119312523063707/0001193125-23-063707-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fourth quarter and year ended December 31, 2022"},{"label":"Revenue","value":"$302 million"},{"label":"Net income","value":"net loss of $77 million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}